Cargando…
Novel Treatment of Hepatitis C Virus Infection for Patients with Renal Impairment
Prevalence of hepatitis C virus (HCV) infection is high in patients with end-stage renal dysfunction, including patients undergoing hemodialysis (HD). The HCV infection itself can cause glomerulonephritis and puts individuals at increased risk of developing end-stage renal disease; fortunately, succ...
Autores principales: | Suda, Goki, Ogawa, Koji, Kimura, Megumi, Nakai, Masato, Sho, Takuya, Morikawa, Kenichi, Sakamoto, Naoya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
XIA & HE Publishing Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225152/ https://www.ncbi.nlm.nih.gov/pubmed/28097101 http://dx.doi.org/10.14218/JCTH.2016.00032 |
Ejemplares similares
-
Treatment of hepatitis C in special populations
por: Suda, Goki, et al.
Publicado: (2018) -
Glecaprevir and Pibrentasvir for Japanese Patients with Human Immunodeficiency Virus and Genotype 3 Hepatitis C Virus Coinfection: A Report of Three Cases
por: Sho, Takuya, et al.
Publicado: (2018) -
Prediction of hepatocellular carcinoma using age and liver stiffness on transient elastography after hepatitis C virus eradication
por: Nakai, Masato, et al.
Publicado: (2022) -
Efficacy of rifaximin against covert hepatic encephalopathy and hyperammonemia in Japanese patients
por: Nakai, Masato, et al.
Publicado: (2022) -
Baseline elevated serum angiopoietin-2 predicts long-term non-regression of liver fibrosis after direct-acting antiviral therapy for hepatitis C
por: Kawagishi, Naoki, et al.
Publicado: (2021)